Market Research Logo

Anti-Infective Drugs Market Global Report 2017 Including: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal)Covering: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi

Anti-Infective Drugs Market Global Report 2017 Including: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal)Covering: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi

Companies in the anti-infective drugs market are very active with multiple strategic collaborations and agreements. Top companies in the anti-infective drugs market are strategically partnering and collaborating with other companies and government agencies to broaden their products, technologies and services.

The Anti-Infective Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs sector.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the anti-infective drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-infective drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The anti-infective drugs market section of the report gives context. It compares the anti-infective drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.
  • The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope

Markets Covered: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal)

Companies Mentioned: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Anti-Infective Drugs Market Characteristics
2. Anti-Infective Drugs Market Size And Growth
2.1. Historic Market Growth
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market
3. Pestle Analysis
3.1. Political
3.2. Economic
3.3. Social
3.4. Technological
3.5. Legal
3.6. Environmental
4. Anti-Infective Drugs Market Customer Information
5. Anti-Infective Drugs Market Segmentation
5.1. Global Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
5.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Segment
5.3 Global Anti-Infective Drugs Market Trends And Strategies
5.3 Global Anti-Infective Drugs Market Trends And Strategies
6. Anti-Infective Drugs Market Regional And Country Analysis
6.1. Global Anti-Infective Drugs Market, 2016, By Region
6.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Region
6.3. Anti-Infective Drugs Market, 2016, By Country
6.4. Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Country
6.5. Global Pharmaceutical Market Segments, 2016, By Region
6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region
6.7. Global Pharmaceutical Market Segments, 2016, By Country
6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country
7. Global Anti-Infective Drugs Market Comparison With Macro Economic Factors
7.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global
7.2. Per Capita Average Anti-Infective Drugs Expenditure, Global
8. Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries
8.1. Anti-Infective Drugs Market Size, Percentage Of GDP, By Country
8.2. Per Capita Average Anti-Infective Drugs Expenditure, By Country
9. Anti-Infective Drugs Market Comparison With Industry Metrics
9.1. Global Number Of Pharmacists, 2016, By Country
9.2. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country
9.3. Global Number Of Pharma Enterprises, 2016, By Country
9.4. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
9.5. Global Average Spending On R&D/Product Development, 2016, By Country
9.6. Global Anti-Infective Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.8. Global Anti-Infective Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.9. Prevalent Cases Of Hiv, 2014, By Country
9.10. Global Number Of General Practitioners 2016, By Country
9.11. Global Anti-Infective Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country
10. Asia-Pacific Anti-Infective Drugs Market
10.1.1. Asia-Pacific Anti-Infective Drugs Market Overview
10.1.2. Asia-Pacific Anti-Infective Drugs Historic Market, 2012 - 2016
10.1.3. Asia-Pacific Anti-Infective Drugs Forecast Market, 2016 - 2020
10.1.4. Asia-Pacific Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
10.2. Asia-Pacific Anti-Infective Drugs Market: Country Analysis
10.3. China Anti-Infective Drugs Market
10.3.1. China Anti-Infective Drugs Market Overview
10.3.2. China Anti-Infective Drugs Historic Market, 2012 - 2016
10.3.3. China Anti-Infective Drugs Forecast Market, 2016 - 2020
10.3.4. China Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
10.3.5. China Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
10.3.6. China Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
10.4. India Anti-Infective Drugs Market
10.4.1. India Anti-Infective Drugs Market Overview
10.4.2. India Anti-Infective Drugs Historic Market, 2012 - 2016
10.4.3. India Anti-Infective Drugs Forecast Market, 2016 - 2020
10.4.4. India Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
10.4.5. India Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
10.4.6. India Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
10.5. Japan Anti-Infective Drugs Market
10.5.1. Japan Anti-Infective Drugs Market Overview
10.5.2. Japan Anti-Infective Drugs Historic Market, 2012 - 2016
10.5.3. Japan Anti-Infective Drugs Forecast Market, 2016 - 2020
10.5.4. Japan Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
10.5.5. Japan Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
10.5.6. Japan Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
10.6. Australia Anti-Infective Drugs Market
10.6.1. Australia Anti-Infective Drugs Historic Market, 2012 - 2016
10.6.2. Australia Anti-Infective Drugs Forecast Market, 2016 - 2020
10.6.3. Australia Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
10.6.4. Australia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
10.6.5. Australia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
11. Western Europe Anti-Infective Drugs Market
11.1.1. Western Europe Anti-Infective Drugs Market Overview
11.1.2. Western Europe Anti-Infective Drugs Historic Market, 2012 - 2016
11.1.3. Western Europe Anti-Infective Drugs Forecast Market, 2016 - 2020
11.1.4. Western Europe Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
11.2. Western Europe Anti-Infective Drugs Market: Country Analysis
11.3. UK Anti-Infective Drugs Market
11.3.1. UK Anti-Infective Drugs Market Overview
11.3.2. UK Anti-Infective Drugs Historic Market, 2012 - 2016
11.3.3. UK Anti-Infective Drugs Forecast Market, 2016 - 2020
11.3.4. UK Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
11.3.5. UK Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
11.3.6. UK Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
11.4. Germany Anti-Infective Drugs Market
11.4.1. Germany Anti-Infective Drugs Historic Market, 2012 - 2016
11.4.2. Germany Anti-Infective Drugs Forecast Market, 2016 - 2020
11.4.3. Germany Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
11.4.4 Germany Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
11.4.5 Germany Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
11.5 France Anti-Infective Drugs Market
11.5.1 France Anti-Infective Drugs Historic Market, 2012 - 2016
11.5.2 France Anti-Infective Drugs Forecast Market, 2016 - 2020
11.5.3 France Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
11.5.4 France Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
11.5.5 France Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
11.6. Italy Anti-Infective Drugs Market
11.6.1. Italy Anti-Infective Drugs Historic Market, 2012 - 2016
11.6.2. Italy Anti-Infective Drugs Forecast Market, 2016 - 2020
11.6.3. Italy Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
11.6.4. Italy Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
11.6.5. Italy Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
11.7. Spain Anti-Infective Drugs Market
11.7.1. Spain Anti-Infective Drugs Historic Market, 2012 - 2016
11.7.2. Spain Anti-Infective Drugs Forecast Market, 2016 - 2020
11.7.3. Spain Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
11.7.4. Spain Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
11.7.5. Spain Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
12. Eastern Europe Anti-Infective Drugs Market
12.1.1. Eastern Europe Anti-Infective Drugs Market Overview
12.1.2. Eastern Europe Anti-Infective Drugs Historic Market, 2012 - 2016
12.1.3. Eastern Europe Anti-Infective Drugs Forecast Market, 2016 - 2020
12.1.4 Eastern Europe Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
12.2. Eastern Europe Anti-Infective Drugs Market: Country Analysis
12.3. Russia Anti-Infective Drugs Market
12.3.1. Russia Anti-Infective Drugs Historic Market, 2012 - 2016
12.3.2. Russia Anti-Infective Drugs Forecast Market, 2016 - 2020
12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment
12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
12.3.4. Russia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
12.3.5. Russia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
13. North America Anti-Infective Drugs Market
13.1.1. North America Anti-Infective Drugs Market Overview
13.1.2. North America Anti-Infective Drugs Historic Market, 2012 - 2016
13.1.3. North America Anti-Infective Drugs Forecast Market, 2016 - 2020
13.1.4. North America Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
13.2. North America Anti-Infective Drugs Market: Country Analysis
13.3. USA Anti-Infective Drugs Market
13.3.1. USA Anti-Infective Drugs Historic Market, 2012 - 2016
13.3.2. USA Anti-Infective Drugs Forecast Market, 2016 - 2020
13.3.3 USA Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
13.3.4. USA Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
13.3.5. USA Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
14. South America Anti-Infective Drugs Market
14.1.1. South America Anti-Infective Drugs Market Overview
14.1.2. South America Anti-Infective Drugs Historic Market, 2012 - 2016
14.1.3. South America Anti-Infective Drugs Forecast Market, 2016 - 2020
14.1.4. South America Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
14.2. South America Anti-Infective Drugs Market: Country Analysis
14.3. Brazil Anti-Infective Drugs Market
14.3.1. Brazil Anti-Infective Drugs Historic Market, 2012 - 2016
14.3.2. Brazil Anti-Infective Drugs Forecast Market, 2016 - 2020
14.3.3. Brazil Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
14.3.4. Brazil Anti-Infective Drugs Percentage Of GDP, 2012 - 2020
14.3.5. Brazil Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020
15. Middle East Anti-Infective Drugs Market
15.1.1. Middle East Anti-Infective Drugs Market Overview
15.1.2. Middle East Anti-Infective Drugs Historic Market, 2012 - 2016
15.1.3. Middle East Anti-Infective Drugs Forecast Market, 2016 - 2020
15.1.4. Middle East Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
16. Africa Anti-Infective Drugs Market
16.1.1. Africa Anti-Infective Drugs Market Overview
16.1.2. Africa Anti-Infective Drugs Historic Market, 2012 - 2016
16.1.3. Africa Anti-Infective Drugs Forecast Market, 2016 - 2020
16.1.4. Africa Anti-Infective Drugs Market, 2016, By Segment
Antibiotics
Antivirals
Antifungals
Others (Antihelmethic, Antiprotozoal)
17. Anti-Infective Drugs Market Competitive Landscape
17.1. Company Profiles
17.2. Pfizer Inc.
17.2.1. Overview
17.2.2. Products And Services
17.2.3. Strategy
17.2.4. Financial Performance
17.3. Glaxosmithkline
17.3.1. Overview
17.3.2. Products And Services
17.3.3. Strategy
17.3.4. Financial Performance
17.4. F. Hoffmann-La Roche Ltd
17.4.1. Overview
17.4.2. Products And Services
17.4.3. Strategy
17.4.4. Financial Performance
17.5. Bristol-Myers Squibb Company
17.5.1. Overview
17.5.2. Products And Services
17.5.4. Financial Performance
17.6. Sanofi
17.6.1. Overview
17.6.2. Products And Services
17.6.3. Strategy
17.6.4. Financial Performance
18. Key Mergers And Acquisitions In The Anti-Infective Drugs Market
19. Market Background: Pharmaceutical Drugs Market
19.1.1. Pharmaceutical Drugs Market Characteristics
19.1.2. Pharmaceutical Drugs Market Historic Growth
19.1.2.1. Drivers Of The Market
19.1.2.2. Restraints Of The Market
19.1.3. Pharmaceutical Drugs Market Forecast Growth
19.1.3.1. Drivers Of The Market
19.1.3.2. Restraints Of The Market
19.1.4. Pharmaceutical Drugs Trends And Strategies
19.2. Pharmaceutical Drugs Market Regional And Country Analysis
19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region
19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region
19.2.3. Pharmaceutical Drugs Market, 2016, By Country
19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country
19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment
19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment
19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors
19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global
19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global
19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country
19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
21.1. NAICS Definitions Of Industry Covered In This Report
21.2. Abbreviations
21.3. Currencies
21.4. Research Inquiries
21.5. The Business Research Company
21.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report